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Distribution of heparin-binding EGF-Iike growth factor protein and
mRNA in the normal rat kidneys. Heparin-binding EGF-like growth
factor (HB-EGF), a newly discovered potent mitogen and chemoattrac-
tant for smooth muscle cells, is a member of the EGF superfamily and
binds to EGF receptors. To investigate the role of HB-EGF in the kidney,
we determined the distribution of HB-EGF immunohistochemically in
normal rat kidneys. The localization of mRNA expression was also studied
by in situ hybridization, using a synthesized digoxigenin-labeled anti-sense
riboprobe of HB-EGF. Inimunohistochemical and in situ hybridization
studies revealed that the tubular epithelial cells of the S3 segment of the
outer stripe in the outer medulla were the predominant renal source of
I-IB-EGF. In addition, in the immunohistochemical analysis, HB-EGF was
ubiquitously present in the epithelial cells of the proximal tubules and the
arterial smooth muscle cells, while HB-EGF expression was not detected
in other parts of the kidney, including the glomeruli. Although EGF
receptors were found to be present in the proximal tubules as well as in the
distal tubules and collecting ducts, EGF has not been found to be
expressed in the proximal tubules. Therefore, the present results indicate
that HB-EGF might be a ligand for EGF receptors in the proximal tubules
and might play a role in the functions of proximal tubules.
of the candidates as a ligand for EGFRs in the kidney. However,
the precise anatomical information about HB-EGF in the kidney
has not been obtained yet. To clarify the localization of HB-EGF
in the kidney, we conducted immunohistochemical and in situ
hybridization studies of HB-EGF in normal rat kidney.
Methods
Materials
Male Wistar rats, Kyoto strain, 300 to 350 g, were used. Under
the anesthesia with pentobarbital (50 mg/kg), the abdominal aorta
was exposed and a 22-gauge needle was inserted into the aorta
caudal to the renal arteries. After the perfusion with 250 ml of
saline, the kidneys were excised, immersed overnight in methyl
Carnoy's solution at 4°C and embedded in paraffin. Sections 2 and
3 m thick were cut for immunohistochemical and in situ hybrid-
ization studies, respectively.
Immunohistochemistiy
EGF, a potent mitogenic peptide, is known to be involved in
various non-mitogenic activities such as ion transport, enhanced
cell migration, and the growth and development of various tissues
[1]. Since the kidney is one of the major sources of EGF, EGF has
been considered to play a key role in renal physiology [2]. The
presence of EGF has been demonstrated in the apical membranes
of the thick ascending limb of Henle's loop and in the distal
convoluted tubules, but not in the proximal tubules [3, 4]. On the
contrary, EGF receptors (EGFRs) were found to be localized in
the basolateral membranes of the proximal tubules as well as in
the distal tubules and collecting ducts [4—6]. Thus, it is not likely
that EGF produced and secreted in the kidneys serves as a ligand
for the EGFRs in the proximal tubules.
Heparin-binding EGF-like growth factor (HB-EGF), a new
member of EGF superfamily, was originally found in the condi-
tioned medium of human monocytes and macrophages [7—91.
HB-EGFwas shown to bind to EGFRs and to promote phosphor-
ylation of EGFR protein [10]. Therefore, HB-EGF might be one
Immunohistochemical staining was performed by the streptavi-
din-biotin immunoperoxidase method. The antibody recognizing
pro-HB-EGF was produced as previously described [11]. In brief,
female New Zealand rabbits were immunized with human syn-
thetic prepeptide H-i (HB-EGF precursor COOH-terminal resi-
dues 185-208, sequence conversion vs. rat; 83%). This antibody
did not react with EGF, TGF-o or amphiregulin by Western
blotting [9]. After deparaffinization, sections were treated with
phosphate-buffered saline containing 0.03% H202 and 0.1%
N2Na to quench the internal peroxidase activity, incubated over-
night in anti-HB-EGF antiserum (SH-1) at 4°C, and then sub-
jected to a three-step immunoperoxidase procedure (SABC-kit,
Nissui, Japan). SH-i immunoreactive products were visualized by
the use of diaminobenzidine as a chromogen. For control staining,
nonimmune rabbit serum and the appropriate secondary antibody
were used. To check the specificity of this antibody, an absorption
test was performed; sections were pre-incubated in the serum that
had been absorbed by H-I, and then processed for further
immunohistochemical staining, as described above.
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Preparation of probe for in situ hybridization
A i28-bp Sad-ScaT (407-535) restriction fragment, which was
spanning from the soluble protein to the transmemhrane coding
region, was inserted into PGEM-4Z in two directions. After
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450
CUC CUCAGUGGGA GCUAGCCAUG CCCAACUUCA CIJUUCUCCUC
ACUUUCCAAG UCAUAACCUC CUCGCCUAUG GUACCUGAAC
500
AUGAGAAGUC CCACGAUGAC AAGAAGACAG ACAGAUGACA
535
GUACU
Fig. 1. The structure ofantisense riboprobe.
linearized, sense and anti-sense riboprobes were synthesized with
T7 polymerase in the presence of digoxigenin-labeled UTP using
T7/SP6 RNA labeling kit (Boehringcr Mannheim, Germany).
The structure of antisense riboprobe was shown in Figure 1.
In situ hybridization procedure
Sections of the kidney were mounted on poly-L-lysine-coated
glass slides, deparaffinized, and fixed for five minutes with 2%
formaldehyde. They were then treated with 10 jsg/ml proteinase K
at 37°C for seven minutes, refixed in 2% formaldehyde and
treated with 0.1 M triethanolamine in 0.25% acetic anhydride.
These sections were incubated with prehybridization solution
(50% formamide, 2 >( SSC with 0.5 mg/mi sonicated salmon
sperm DNA (Pharmacia, Uppsala, Sweden), 0.5 mg/mI yeast
tRNA (Sigma Chemical Co., St. Louis, MO, USA), 0.5 mg/mI
heparin and 1 x Denhardt's solution) at room temperature for 60
minutes. Sections were then hybridized with 0.5 .tg/m1 digoxige-
nm-labeled cRNA probe in prehybridization solution supple-
mented with 10% dextran sulfate (Pharmacia) and 0.1% Tween 20
at 48°C overnight. After hybridization, sections were washed in
2 X SSC at room temperature for 25 minutes, in 1 X SSC at 55°C
for 25 minutes, in 0.5 x SSC at 55°C for 25 minutes, and finally in
0.5 X standard sodium citrate (SSC) at room temperature for 25
minutes. Slides were then rinsed in Tris-buffered saline (Tris-HC1,
150 mM NaCI; pH 7.5) for five minutes at room temperature prior
to being incubated with alkaline phosphatase-conjugated anti-
digoxigenin antibody (Boehringer Mannheim) at 1:1000 dilution
at room temperature for one hour. After washing in Tris buffered
saline (PH 9.5), the development solution containing nitrobluetet-
razolium (NBT; Boehringer Mannheim) was applied according to
manufacturer's protocol and the slides were placed in a dark moist
chamber. After one to two hours, the color reaction was stopped
with a water wash. Slides were air dried and coverslipped over
Entellan (Merck, Darmstadt, Germany).
To evaluate the specificity of the technique, a study with a sense
probe that was complementary to the antisense probe and a
competitive study using excess amounts (50- and 100-fold) of
unlabeled aritisense probes were performed.
Identification of individual nephron segments
The individual nephron segments were identified by the method
reported by Heilig et a! [121. The SI segments of the proximal
tubules in the renal cortex were identified by the brush borders of
their epithelial cells and by direct connection with glomeruli. The
S2 segments of the proximal tubules were identified as cortical
tubular segments possessing brush borders not directly in contact
with glomeruli. The S3 segments of the proximal tubules were
identified as brush border possessing tubules of the outer stripe in
the outer medulla and medullary lays of the cortex. Thin limbs
Fig. 2. Identification of HB-EGF localization in the renal cortex of a normal
kidney. (a) HB-EGF expression is observed in the apical membranes of
tubular epithelia of proximal tubules. Glomerulus shows negative immuno-
staining. The distal tubules and thick ascending limbs are also negative. (b)
THP stainings arc found in the distal convoluted tubules and thick ascending
limbs. (c) Intense stainings for PNA are seen in the distal tubules, thick
ascending limb and collecting ducts. Weak stainings are found on the brush
border of proximal convoluted tubular cells. The glomcrulus is entirely
negative. Abbreviations are: P, proximal tubule; G, glomerulus; D, distal
tubule; T, thick ascending limb; C, collecting duct (X200).
were identified as nonvascular, small-diameter tubule segments in
the inner medulla with flattened epithelial cells. They were also
frequently identified at their connections with thick ascending
limbs of Henle at the junction of the outer medulla and inner
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Fig. 3. Photomicrograph of the outer stripe of the outer medulla of a normal
rat. Note that immunoreactive products are localized in the apical
membranes of tubular epithelia in the S3 segment of proximal tubules,
while collecting ducts are negative for immunoreactivity. Weak immuno-
reactivity (arrow) is observed also in the cytoplasm of proximal tubular
cells in the S3 segment (HB-EGF immunostaining, x200).
medulla. Thick limbs of Henle were identified in the outer
medulla by their broad, tall cells and large diameter tubule
segments lacking brush borders. Distal tubules were identified in
the cortex as tubule segments lacking a brush border, distinctly
smaller than the large diameter cortical collecting tubules and
having cells with centrally placed nuclei, rather than the basally
located nuclei seen in collection duct cells. Medullary collecting
tubules were identified in the inner medulla by their wide
diameter and cuboidal cells.
To further identify the individual nephron segments, Tamm-
Horsfall protein (THP) and peanut agglutinin (PNA) stainings
were performed. Mouse monoclonal antibody to THP, obtained
from Cedarlane Laboratories (Ontario, Canada), was used at a
dilution of 1:2000. Biotinylated PNA (Biomed, Foster, CA, USA)
was used at 2.5 ig/ml. THP was shown to be localized in the distal
convoluted tubule and thick ascending limb. Positive staining for
PNA was found in proximal convoluted tubules, distal tubules and
collecting duct, but not in the glomeruli or proximal straight
tubules [13].
Results
Immunohistochemical staining
To identify the localization of HB-EGF in normal kidney, we
first performed the immunohistochemical staining using anti-HB-
EGF antiserum (SH-1). As shown in Figure 2a, all epithelial cells
in the proximal tubules showed positive immunoreactivity for
HB-EGF. Glomeruli, the thick ascending limbs, and the distal
tubules and collecting ducts were all entirely negative. THP, a
marker for the distal convoluted tubule and the thick ascending
limb [131, was not stained in the nephron segments where
HB-EGF was expressed (Fig. 2b). The pattern of staining of PNA
(Fig. 2c) was different from that of HB-EGF, although a weak
staining of PNA was observed in the proximal tubules [13] where
HB-EGF was present.
In a high power view, immunoreactive products were visible in
the apical membranes of proximal tubular epithelial cells. In the
Fig. 4. HB-EGF immunostaining. Patchy immunostaining is observed in
the wall of interlobular artery of a normal rat kidney. Some of the
endothelial and smooth muscle cells show a positive reaction (X400).
S3 segment, immunoreactivity was also detected in the cytoplasm
(Fig. 3). Patchily distributed immunoreactive products were also
found in the smooth muscle cells of arteries (Fig. 4).
Control staining with nonimmune rabbit serum was completely
negative (data not shown). Immunoreactivity for HB-EGF was
completely abolished by pre-incubation with an excess amount of
immunizing peptide (Fig. 5). A summary of the immunohisto-
chemical results are shown in Figure 6.
In situ hybridization
The expression of HB-EGF mRNA was examined by in situ
hybridization in normal rat kidneys. In the low power view,
hybridization signals were observed mainly in the outer stripe in
the outer medulla without any detectable hybridization in the
cortex or inner medulla (Fig. 7a). The DIG-labeled HB-EGF
sense probe yielded no positive signals (Fig. 7b). In the high power
views, expression of HB-EGF mRNA was distributed in the S3
segment of the proximal tubules, but not in the collecting ducts.
Intense hybridization signals were localized within the cytoplasm
of tubular epithelial cells (Fig. 8).
The addition of a 100-fold excess of unlabeled HB-EGF
antisense probe to the standard hybridization mixture containing
the DIG-labeled HB-EGF probe completely abolished the posi-
tive signals (Fig. 9). A summary of the in situ hybridization's
results are shown in Figure 10.
Discussion
The present study clearly indicates that HB-EGF mRNA is
expressed in the epithelial cells of the proximal tubules of the
outer stripe in the outer medulla, but not in the glomeruli or other
parts of the nephron. The specificity of the signals in the in situ
hybridization was confirmed by both the competitive study with an
excess amount of unlabeled homologous probe and the control
study with a sense probe. In the immunohistochemical study with
SH-1, the immunoreactivity for HB-EGF was detected in the
proximal tubules of the SI to S3 segments. No immunoreactivity
was observed in the glomeruli, the loop of Henle, the distal
tubules, or collecting ducts.
Although both mRNA and protein of HB-EGF were detected
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Fig. 5. HB-EGF immunostaining. Immunoreactive products of HB-EGF observed in the proximal tubules (a) are completely abolished after
pre-incubation with an excess amount of recombinant HB-EGF peptide (b) (X400).
than immunohistochemistry. The negative finding for HB-EGF in
Si and S2 in the in situ hybridization study, as compared with
positive findings in Si to S3 in the immunohistochemistrical study,
might be explained by a smaller amount of mRNA in Si and S2
than in S3. Alternatively, HB-EGF detected in Si and S2 seg-
CCD ments by immunohistochemistry might be the result of binding
and/or endocytosis of HB-EGF that was derived from nephron
arterial sites.
OSOMCD EGF was demonstrated to be a potent mitogen for cultured
epithelial cells from the proximal tubules [141. In the ischemiai'
ISOMCD reperfusion model, the treatment with synthetic EGF peptide was
_____
found to induce the regeneration of injured epithelial cells in the
S3 segment of the proximal tubule [15]. These observations
MCD suggest that EGF could work as a mitogen in the proximal tubules.
Indeed, EGFRs were found to be present in the proximal tubules as
well as in the distal tubules and collecting ducts [4—61. However, the
expression of EGF was shown to be restricted in the thick ascending
limb and distal convoluted tubules, not in the proximal tubules in the
normal kidney [2]. Therefore, the present study indicates that
HB-EGF produced in the proximal tubules may be a ligand for
EGFRs in that portion of the kidney. The importance of HB-EGF in
the diseased kidney has been recently reported. The expression of
HB-EGF mRNA in the kidney was shown to be dramatically
increased as early as one hour after ischemia/reperfusion injuly [16].
In the streptozotocin-induced diabetic rat, HB-EGF mRNA in the
kidney was also found to be enhanced [17]. These findings and the
present results suggest that HB-EGF may play an important role in
both normal and diseased kidneys.
The physiological role of HB-EGF has not been clarified yet.
Because EGF was found to stimulate Na/H exchange in
cultured fibroblasts [18] and to suppress vasopressin-dependent
water transport in the cortical collecting tubules [19], HB-EGF
PT DT
S2
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Fig. 6. Schematic representation of the distribution of HB-EGF protein
within the nephron. HB-EGF peptide is strongly expressed in the S3
segment, and moderately in the Si and S2 segments of the proximal
tubule. Abbreviations are: Glom, glomerulus; CTAL, cortical thick as-
cending limb; MTAL, medullary thick ascending limb; CCD, cortical
collecting duct; OSOMCD, outer stripe of outer medullary collecting duct;
ISOMCD, inner stripe of outer medullary collecting duct; IMCD inner
medullary collecting duct. Symbols are: (LI) (—); () (+); (•) (++).
in the proximal tubules, the distribution of HB-EGF within the
proximal tubules was slightly different between two methods. The
difference might be due to the difference of sensitivities between
these two methods. In situ hybridization seems to be less sensitive
Fig. 8. In situ hybridization with HB-EGF antisense probe. Intense signals
are localized in the cytoplasm of proximal tubules, but arc not observed in
the collecting ducts (CD) (X400).
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tion revealed that the tubular epithelial cells of the S3 segments of
the outer stripe in the outer medulla were the predominant renal
source of HB-EGF. Immunohistochemical study showed HB-
EGF was ubiquitously present in the proximal tubules and in
arterial smooth muscle cells. Since EGF receptors were found to
be present in the proximal tubule where EGF was not expressed,
the HB-EGF localized in the proximal tubules is likely to be a
ligand for EGF receptors and to play an important role as a
cytokine in the normal kidney.
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might be involved in the ion transport in the proximal tubule.
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functions of HB-EGF produced in normal rat kidney.
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